||5R21CA124336-02 Interpret this number
||University Of Alabama At Birmingham
||Patient Reported Outcomes of Cervical Screening in Hiv+ Women in Zambia
In 2004, 1 woman died from invasive cervical cancer (ICC) worldwide for every 5 women who died from
HIV/AIDS and 1 woman died from ICC in Africa for 5 women who died from tuberculosis. In Zambia, the
second country with the highest ICC burden in the world after Tanzania, adherence to follow-up
recommendation is currently low among women screened for cervical precursor lesion, and there is anecdotal
evidence that participants experience substantial anxiety and screening-related distress. In this R21
exploratory/developmental proposal written in response to PA-06-351 for Behavioral Research in Cancer
Control, we intend to carry out formative and patient-centered research (1) to assess the short-term effects of
screening by Visual Inspection of the cervix after application of Acetic Acid (VIA) on the health-related quality
of life (HRQoL) of HIV+ and HIV- women in Lusaka, Zambia; (2) to compare the acceptability of existing
screening protocols and screening options in development but not yet available. The proposed study will
serve as an empirical foundation for the design and conduct of an intervention trial aiming at minimizing
psychosocial harms and increasing acceptability of cervical screening. The R21 study will be conducted in the
following four phases:
We will culturally adapt and rigorously translate the SF-36v2 Health Survey, the Cervical Dysplasia Distress
Questionnaire, and state scale of the Spielberger's State-Trait Anxiety Inventory (6-item version) in two
languages widely spoken in the Southern African region. We will also test the feasibility of using Discrete
Choice Experiments to uncover women's preferences for VIA screening and alternative screening options
currently in early testing phase. Then, we will interview 360 women offered VIA screening at CIDRZ
clinics in Lusaka at baseline, before screening. Women who accept to undergo testing will be
interviewed two more times, immediately after cervical screening and at 1-month post-screening. Data
generated will be used to validate the instruments and methods adapted in the Development Phase, and test
research hypotheses about adverse outcomes and acceptability of low-technology cervical screening in
Zambia. Estimates of quality weights for screening-related health states will also be generated as a study
byproduct. With one woman dying from cervical cancer worldwide for every five women who die from HIV/AIDS, low-
technology cervical screening programs are increasingly proposed as imperfect but potentially cost-effective
approaches to reduce cervical cancer burden in the developing world. This exploratory research project
aims to identify ways to maximize the acceptability of same-day cervical cancer screening and
treatment, minimize the adverse psychosocial consequences of screening, and ensure adherence to
post-screening recommendations among both HIV-infected and HIV-uninfected women attending
outpatient clinics in Lusaka, Zambia.
'Worse than HIV' or 'not as serious as other diseases'? Conceptualization of cervical cancer among newly screened women in Zambia.
White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Moneyham L, Grimley DM, Chamot E
Soc Sci Med, 2012 May;74(10), p. 1486-93.
2012 Mar 7.
Motivations and experiences of women who accessed "see and treat" cervical cancer prevention services in Zambia.
White HL, Mulambia C, Sinkala M, Mwanahamuntu MH, Parham GP, Kapambwe S, Moneyham L, Kempf MC, Chamot E
J Psychosom Obstet Gynaecol, 2012 Jun;33(2), p. 91-8.
2012 Feb 28.
Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review.
Chamot E, Kristensen S, Stringer JS, Mwanahamuntu MH
BMC Womens Health, 2010 Apr 1;10, p. 11.
2010 Apr 1.